Sovos is a global provider of tax, compliance, and trust solutions and services that enable businesses to navigate an increasingly regulated world with true confidence.
More than 100,000 customers in 100+ countries - including half the Fortune 500 – trust Sovos for their compliance needs. Sovos annually processes more than three billion transactions across 19,000 global tax jurisdictions. Bolstered by a robust partner program more than 400 strong, Sovos brings to bear an unrivaled global network for companies across industries and geographies. Founded in 1979, Sovos has operations across the Americas and Europe, and is owned by Hg and TA Associates.
Learn more
Okyline is an Executable Data Design (EDD) platform focused on executable validation contracts and operational data quality control.
Rather than managing separate specifications, validation code, tests, and monitoring dashboards, Okyline centralizes validation and quality supervision around a single readable executable contract acting as the operational reference for enterprise data flows.
The same contract powers deterministic validation, advanced business invariant checks, multi-format execution, data quality gates, and historical quality analytics across APIs, events, files, LLM structured outputs, and distributed operational systems.
Contracts are designed directly from annotated sample data, making validation rules immediately understandable for developers, architects, QA teams, and business analysts.
The Community Edition includes the public specification, a free Java runtime engine, a Claude AI assistant for contract generation, and an online studio supporting executable JSON validation contracts and JSON Schema transpilation.
The Enterprise Edition adds native validation for JSONL, XML, CSV, FIXED, and EDI flows together with operational quality dashboards and data quality gates, without requiring databases or centralized infrastructure.erprise Edition supports direct validation of JSON, JSONL, XML, CSV, FIXED, and EDI flows with operational quality dashboards and analytics, without databases.
Learn more
Medidata
The Medidata Clinical Cloud represents our innovative platform designed to revolutionize the clinical trial journey for patients, sponsors, CROs, and research institutions. As the sole comprehensive technology solution focused exclusively on clinical research, the Medidata Clinical Cloud addresses the entire research spectrum from inception to completion. Our platform enables organizations in the life sciences and medical device sectors to reduce development expenses, manage risks effectively, and expedite the introduction of treatments and devices to the marketplace. Whatever selection you make for your clinical trial initiatives, you will benefit from the capabilities of the Medidata Clinical Cloud. At Medidata, we are at the forefront of the digital evolution in clinical research. With the power of artificial intelligence, machine learning, and sophisticated analytics, our platform connects researchers, study coordinators, investigators, and patients, thereby hastening the research process. Additionally, it provides a regulatory-compliant, patient-friendly electronic informed consent solution for clinical trials, ensuring a smoother experience for all parties involved. This integration of advanced technology not only streamlines operations but also enhances the overall quality of clinical research.
Learn more
Castor EDC
Castor offers an intuitive and comprehensive platform for managing clinical trial data, focusing on electronic data capture (EDC), eConsent, and patient-reported outcomes (ePRO). The platform is optimized for decentralized trials, providing seamless tools for remote patient engagement and data collection. With real-time reporting, Castor helps researchers track trial progress and make data-driven decisions. The solution ensures compliance with industry regulations such as HIPAA, GDPR, and 21 CFR Part 11, making it ideal for life sciences organizations looking to enhance trial efficiency while maintaining high data integrity.
Learn more
